American Board of Internal Medicine (ABIM) Certification Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the ABIM Certification Exam. Use flashcards and multiple choice questions, with hints and explanations for each. Get ready to succeed!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

What is the suggested interval for measuring serum aminotransferase levels in patients on interferon beta?

1 to 2 months
3 to 6 months
6 to 12 months
Every month

The correct answer is: 3 to 6 months

The suggested interval for measuring serum aminotransferase levels in patients on interferon beta therapy is 3 to 6 months. This recommendation stems from the potential for hepatotoxicity associated with interferon beta, leading to elevated liver enzymes. Monitoring these levels within this timeframe allows for the timely identification of any liver function abnormalities while minimizing unnecessary frequent testing. Testing every month, while thorough, may not be necessary and could lead to increased patient burden and healthcare costs without significant benefit, as serious liver issues typically manifest over a longer period. Likewise, intervals longer than 6 months may delay the diagnosis of hepatotoxicity, making it important for healthcare providers to strike a balance between vigilance and practicality in monitoring liver health during treatment with interferon beta.